Everolimus News and Research

RSS
Mcl-1 inhibition blocks cell survival in ER+ breast cancers

Mcl-1 inhibition blocks cell survival in ER+ breast cancers

Rapamycin is more effective at slowing down aging, says researcher

Rapamycin is more effective at slowing down aging, says researcher

Study: Revascularization with PCI or CABG prolongs survival in patients with left main disease

Study: Revascularization with PCI or CABG prolongs survival in patients with left main disease

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

Shorter duration DAPT after PCI did not increase adverse events in high-bleeding risk patients, finds study

New combination treatment shows promise for common brain tumor in children

New combination treatment shows promise for common brain tumor in children

Physicians more likely to prescribe drugs of manufacturers who paid them money

Physicians more likely to prescribe drugs of manufacturers who paid them money

Study shows novel strategy to reduce breast cancer bone metastasis

Study shows novel strategy to reduce breast cancer bone metastasis

Toxic effects of drugs in the lungs 'more widespread than thought'

Toxic effects of drugs in the lungs 'more widespread than thought'

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Drug treatment at a young age could help reverse autism-like behavior in tuberous sclerosis

Drug treatment at a young age could help reverse autism-like behavior in tuberous sclerosis

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Drug coated balloons are as good as stent implants for treating small blocked arteries

Drug coated balloons are as good as stent implants for treating small blocked arteries

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Unbiased approach reveals how to restore breast cancer drugs’ tumor-killing potential

Unbiased approach reveals how to restore breast cancer drugs’ tumor-killing potential

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

New targeted treatment could benefit patients with certain pancreatic tumors

New targeted treatment could benefit patients with certain pancreatic tumors